Home > Healthcare > Pharmaceuticals > Finished Drug Form > Growth Hormone Market
Growth Hormone Market Size
- Report ID: GMI5042
- Published Date: Jul 2023
- Report Format: PDF
Growth Hormone Market Size
Growth Hormone Market size was worth over USD 3.3 billion in 2022. Driven by the growing prevalence of growth hormone deficiency globally, the industry could grow at over 6% CAGR from 2023 to 2032.
Rising occurrence of growth hormone deficiency (GHD) attributed to brain injuries, genetic disorders, congenital conditions, and certain medical treatments has increased the need for growth hormone therapies. As per NCBI, pediatric growth hormone deficiency is diagnosed in 1 in every 3,500–4,000 children in the UK. Moreover, rising R&D activities in the growth hormone space are further contributing to industry growth. For instance, in February 2022, Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection received marketing authorization from the European Union for the Treatment of Pediatric Growth Hormone Deficiency.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Growth Hormone Market Size in 2022: | USD 3.3 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6% |
| 2032 Value Projection: | USD 5.8 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 160 |
| Tables, Charts & Figures: | 220 |
| Segments covered: | Product, Application, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Growth Hormone Market Scope
